Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Income | -167 | -224 | -260 |
| Net Income | -169 | -222 | -246 |
| EBITDA | -158 | -214 | -237 |
| EPS Diluted | -2.68 | -3.26 | -2.92 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 233 | 141 | 56 |
| Total Current Assets | 392 | 364 | 378 |
| Total Assets | 497 | 552 | 566 |
| Total Current Liabilities | 22 | 39 | 49 |
| Total Liabilities | 42 | 62 | 74 |
| Total Equity | 455 | 490 | 493 |
| Total Debt | 23 | 23 | 25 |
| Net Debt | -210 | -118 | -31 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -121 | -178 | -195 |
| Capital Expenditure | -8 | -9 | -16 |
| Free Cash Flow | -129 | -187 | -211 |
| Stock-Based Comp | 29 | 31 | 39 |
| Net Change in Cash | -65 | -92 | -85 |